非洲国家药品监管机构的监管绩效 实现世卫组织成熟度三级:确定最佳实践
Mercy Owusu-Asante1,2, Delese Mimi Darko2, Boitumelo Semete-Makokotieia3
1School of Health, Medicine and Life Sciences, University of Hertfordshire, Hatfield, Herts, AL10 9AB, UK.
Therapeutic innovation & regulatory science
|October 27, 2025
概括
非洲监管机构在早期标签审查方面表现出优势,但面临人力资源缺口. 该研究确定了达到成熟度3级及以上的最佳实践,旨在改善监管流程和药物获取.
科学领域:
- 制药法规 制药法规 制药法规
- 公共卫生政策 公共卫生政策
- 药物安全和有效性 药物安全和有效性
背景情况:
- 世界卫生组织 (WHO) 开发了全球基准测试工具 (GBT) 来评估国家药物监管机构 (NMRA).
- 六个非洲NMRA (埃及,加纳,尼日利亚,南非,坦桑尼亚,津巴布韦) 具有WHO GBT成熟度级别3被选中进行比较分析.
研究的目的:
- 确定非洲国家药物监管机构的药物监管体系的优势和改进领域.
- 为了比较监管绩效,并加强审查流程,以改善患者获得药物和疫苗的机会.
主要方法:
- NMRA 填写了一份问卷,收集数据和指标进行比较分析.
- 对监管绩效和审查过程绘制的比较研究.
主要成果:
- 当局之间的相似之处有助于它们发现的优势.
- 人力资源能力不足阻碍了非洲国家监管机构 (NMRAs) 充分执行监管任务.
- 标签审查由这些NMRA在过程的早期进行.
结论:
- 确定了监管最佳实践,使NMRA能够达到WHO GBT成熟度水平3.
- 非洲药物管理局 (AMA) 应利用成熟度级别-3 NMRA 的经验和资源.
- 解决发现的差距可以帮助NMRA实现WHO GBT成熟度水平4并支持其他人达到更高的成熟度水平.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
485
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
485
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
International Nursing Organizations II
1.3K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.3K
Therapeutic Drug Monitoring: Drug Analysis Methods
172
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
172
Global Regulatory Systems
593
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
593


